Lawrence Panasci

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial

Timothy J. Whelan, Jim A. Julian, Tanya Berrang et al. · The Lancet · 2019 · 424 citations

Medicine, Oncology, Surgery +17

A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213.

Vanessa Bernstein, Susan Ellard, Susan Dent et al. · Breast Cancer Research and Treatment · 2017 · 101 citations

Medicine, Oncology, Pharmacology +14

Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B Study 8662.

Daniel F. Hayes, Hideko Yamauchi, Gloria Broadwater et al. · PubMed · 2001 · 96 citations

Medicine, Cancer Biology, Oncology +17

A phase II trial of ZD1839 (Iressa™) 750 mg per day, an oral epidermal growth factor receptor-tyrosine kinase inhibitor, in patients with metastatic colorectal cancer

Mary J. MacKenzie, Holger W. Hirte, Glenwood D. Goss et al. · Investigational New Drugs · 2005 · 67 citations

Medicine, Oncology, Pharmacology +14

Correlation of resistance to nitrogen mustards in chronic lymphocytic leukemia with enhanced removal of melphalan-induced DNA cross-links

San Juana Torres-Garcia, Linda Cousineau, Stephen Caplan et al. · Biochemical Pharmacology · 1989 · 61 citations

Medicine, Cancer Biology, Oncology +11